Purpose: Approach:
Introduction SEDDS (Self-Emulsifying Drug Delivery System) are defined as isotopic mixtures of natural, syntheticoils, surfactants or alternatively one or more hydrophilic solvents and co solvents and 1, 2 surfactants. SEDDS is one of the best choices for the formulators to overcome the problem of solubility and bioavailability of many hydrophobic drugs. Hence it has received meticulous attention as a means of enhancing oral bioavailability of poorly soluble drugs. SEDDS formulation disperse into fine emulsion droplets inside the lumen of the gut where drug remains in solution state avoiding the dissolution step that frequently limit the rate of absorption of hydrophobic drugs from the crystalline form. The mechanism of self emulsification occurs when the entropy change that favours dispersion is greater than the energy required to increase the surface area of the dispersion. The potential advantages of this system include enhance oral bioavailability, enabling reduction in dose, more consistent temporal profile of drug absorption, selective targeting of drug towards specific absorption window in gastro intestinal tract and protection of drug from the hostile environment in gut. SEDDS are physically stable formulations which have a high extent of absorption and more reproducible plasma concentration profile easy to manufacture. An additional advantage of SEDDS over simple oily solutions is that they provide a large interfacial area for partitioning of the drug between oil and water. Thus, SEDDS can be an efficient vehicle for class II to Class IV molecules of
MECHANISM OF SELF-EMULSIFICATION
Self emulsification occurs, when the entropy (energy) change occurs. The free energy of conventional emulsion formation is a direct function of the energy required to create a new surface between the two phases and can be described by the equation. 2 ? G = S N p r s Where, ? G is the free energy associated with the process (ignoring the free energy of mixing), N is the number of droplets of radius r, s is interfacial energy with time. The two phases of the emulsion will tend to separate, in order to reduce the interfacial area and subsequently, the free energy of the system. Therefore, the emulsions resulting from aqueous dilution are stabilized by conventional emulsifying agents, which form a monolayer around the emulsion dropletsand hence, reduce the interfacial energy, as well as providing a barrier to coalescence. In case of self-emulsifying system, the free energy requires to form the emulsion is either very low or positive or negative then, the emulsion process occurs spontaneously. Emulsification require very little input energy, involves destabilization through contraction of local interfacial regions. For emulsification to occur, it is necessary for the interfacial structure to have no resistance to surface shearing. Emulsification can be associated with the ease by which water penetrates into the various liquid crystals or phases get formed on the surface of the droplet. The addition of a binary mixture (oil/nonionic surfactant) to the water results in the interface formation between the oil and aqueous continuous phases, followed by the solubilisation of water within the oil phase owing to aqueous penetration through the interface, which occurs until the solubilisation limit is reached close to the interface. Further, aqueous penetration will result in the formation of the dispersed liquid crystalline phase. As the aqueous penetration proceeds, eventually all materials close to the interface will be liquid crystal, the actual amount depending on the surfactant concentration in the binary mixture once formed, rapid penetration of water into the aqueous cores, aided by the gentle agitation of the selfemulsification process causes interface disruption and droplet formation. The high solubility of these self-emulsified systems to coalescence is considered to be due to liquid crystal interface surrounding the 4, 5 oil droplets. where the hydrophilic group carries a positive charge. Example: quaternary ammonium halide. C) Ampholytic surfactants: -(also called zwitterionic surfactants) contain both a negative and a positive charge. Example: sulfobetaines. D) Non-ionic surfactants: -where the hydrophilic group carries no charge but derives its water solubility from highly polar groups such as hydroxyl or polyoxyethylene. Examples: Sorbitan esters (Spans), poly sorbates (Tweens).
EXCIPENTS USED IN SEDDS

C) CO-SOLVENTS :
The production of an optimum SEDDS requires relatively high concentrations (generally more than 30% w/w) of surfactants, thus the concentration of surfactant can be reduced by incorporation of co-surfactant. Role of the co-surfactant together with the surfactant is to lower the interfacial tension to a very small even transient negative value. At this value the interface would expand to form fine dispersed droplets, and subsequently adsorb more surfactant and surfactant/co-surfactant until their bulk condition is depleted enough to make interfacial tension positive again. However, the use of cosurfactant in self emulsifying systems is not mandatory for many non-ionic surfactants. The selection of surfactant and co-surfactant is crucial not only to the formation of SEDDS, but also to solubilisation of the drug in the 5, 6 SEDDS.
DOSAGE FORM OF SEDDS:
Oral delivery: v v v (1)
S e l f e m u l s i f y i n g c a p s u l e :
A f t e r administration of capsules containing conventional liquids SEDDS formulations, microemulsion droplets form and subsequently disperse in the GIT to reach site of absorption. If irreversible phase separation of microemulsion occurs an improvement of drugs absorption can't be expected. For handling this problem, sodium dodecyl sulphate was added into the SEDDS formulation Self emulsifying sustained / controlled release: Combination of lipids and surfactant has presented great potential preparing SE tablets. SE tablets are of great utility in obviating adverse effect. Inclusion of Indomethacin (or other hydrophobic NSAID) for example, into SE tablets may increase its penetration efficacy through GI mucosal membrane, potentially reducing GI bleeding. Self emulsifying sustained / controlled release pellets: Pellets, as a multiple unit dosage for m, possess many advantages over conventional solid dosage form, such as flexibility of manufacture, reducing intra subject and inter subject variability of plasma profile and minimizing GI irritation without lowering drug bioavailability. (2) Dispersibility test:
The efficiency of self-emulsification of oral nano or micro emulsion is assessed using a standard USP XXII dissolution apparatus 2. One millilitre of each formulation was added to 500 ml of water at 37 ± 0.5 °C. A standard stainless steel dissolution paddle rotating at 50 rpm provided gentle agitation. The in vitro performance of the formulations is visually assessed using the following grading system: Grade A: Rapidly forming (within 1 min) nanoemulsion, having a clear or bluish appearance. Grade B: Rapidly forming, slightly less clear emulsion, having a bluish white appearance. Grade C: Finemilky emulsion that formed within 2 min. Grade D: Dull, greyish white emulsion having slightly oily appearance that is slow to emulsify (longer than 2 min). Grade E: Formulation, exhibiting either poor or minimal emulsification with large oil globules present on the surface.
Grade A and Grade B formulation will remain as nanoemulsion when dispersed in GIT. While formulation falling in Grade C could be recommend for SEDDS formulation.
(3) Turbidimetric Evaluation:
Nepheloturbidimetric evaluation is done to monitor the growth of emulsification. Fixed quantity of Selfemulsifying system is added to fixed quantity of suitable medium (0.1N hydrochloric acid) under continuous stirring (50 rpm) on magnetic plate at ambient temperature, and the increase in turbidity is measured using a turbid meter. However, since the time required for complete emulsification is too short, it is not possible to monitor the rate of change of turbidity (rate of emulsification).
(4) Viscosity Determination:
The SEDDS system is generally administered in soft gelatine or hard gelatine capsules. So, it can be easily pourable into capsules and such system should not too thick to create a problem. The rheological properties of the micro emulsion are evaluated by Brookfield viscometer. This viscosities determination conform whether the system is w/o or o/w. If the system has low viscosity then it is o/w type of system and if it high viscosities then it is w/o type of the system. The droplet size of the emulsions is determined by photon correlation spectroscopy (which analyses the fluctuations in light scattering due to Brownian motion of the particles) using a Zetasizer able to measure sizes between 10 and 5000 nm. Light scattering is monitored at 25°C at a 90° angle, after external standardization with spherical polystyrene beads. The nanometric size range of the particle is retained even after 100 times dilution with water which proves the system's compatibility with excess water. Refractive Index and Percent The SEDD system contains ionic or non-ionic surfactant, oil, and water. So, this test is used to measure the elect conductive nature of system. The electro conductivity of resultant system is measured by electro conductormeter.
(8) In Vitro Dissolution Study:
In vitro dissolution studies are performed to study the release behaviour of formulation from liquid crystalline phase around the droplet using dialysis technique.
(9) Drug content: Drug from pre-weighed SEDDS is extracted by dissolving in suitable solvent. Drug content in the solvent extract was analyzed by suitable analytical method against the standard solvent solution of 9, 10 drug.
Below 
Improvement
v Improvement in Solubility and bioavailability: If drug is incorporated in SEDDS, it increases the solubility because it circumvents the dissolution step in of Class-? drug (Low solubility/high permeability). Ketoprofen, a moderately hydrophobic nonsteroidal anti-inflammatory drug (NSAID), is a drug of choice for sustained release formulation has high potential for gastric irritation during chronic therapy. Also because of its low solubility, Ketoprofen shows incomplete release from sustained release formulations. This formulation enhanced bioavailability due to increase the solubility of drug and minimizes the gastric irritation. Also incorporation of gelling agent in SEDDS sustained the release of Ketoprofen. In SEDDS, the lipid matrix interacts readily with water, forming a fine particulate Oil in-water (o/w) emulsion. The emulsion droplets will deliver the drug to the gastrointestinal mucosa in the dissolved state readily accessible for absorption. Therefore, increase in AUC i.e. bioavailability and Cmax is observed with many drugs when presented in SEDDS.
v Protection against Biodegradation:
The ability of self emulsifying drug delivery system to reduce degradation as well as improve absorption may be especially useful for drugs, for which both low solubility and degradation in the GI tract contribute to a low oral bioavailability. Many drugs are degraded in physiological system, may be because of acidic PH in stomach, enzymatic degradation or hydrolyte Such drugs when presented in the form of SEDDS can be well protected against these degradation processes as liquid crystalline phase in SEDDS might act as a barrier between degradating environment and the drug. Ex: -Acetylsalicylic acid a drug that degrades in the GI tract because it is readily hydrolyzed to salicylic acid in an acid environment. The oral bioavailability of undegradedacetylsalicylic acid is improved by 73% by the Galacticles Oral Lipid Matrix v Controlling the release of drug:
Different formulation approaches that have been sought to achieve sustained release, increase the bioavailability, and decrease the gastric irritation of Ketoprofen include preparation of matrix pellets of nanocrystalline Ketoprofen , sustained release Ketoprofenmicro particles and floating oral Ketoprofen systems and transder mal systems of Ketoprofen. Preparation and stabilization of nano-crystalline or improved solubility forms of drug may pose processing, stability, and economic problems. This problem can be successfully overcome when Ketoprofen is presented in SEDDS formulation. This formulation enhanced bioavailability due to increase the solubility of drug and minimizes the gastric irritation. Also incorporation of gelling agent in SEDDS sustained the release of [10, 11] Ketoprofen.
ADVANTAGES OF SEEDS:
11,12
DISADVANTAGES OF SEDDS FUTURE TRENDS IN SEDDS DEVELOP-MENT:
Ø profile.
SEDDS :
Self-emulsifying Drug Delivery System is a formulation approach which is used to increase the solubility of hydrophobic drugs and to make a stable emulsion.
Hydrophobic Drugs: These are the heterogeneous drug molecules that exhibit poor solubility in water but that are typically, but certainly not always, soluble in various organic solvents.
Micro emulsions: Dispersion made of water, oil, and surfactant(s) that is an isotropic and thermodynamically stable system with dispersed domain diameter varying approximately from 1 to 100 nm, usually 10 to 50 nm.
Lipid based systems:
It's a system that has an impact on solubility, permeability, absorption, distribution, and metabolism; to produce physically and chemically stable formulations that offer safe and effective means to deliver drugs to the intended site of absorption/action.
GLOSSARY:
